Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients

被引:24
|
作者
Jia, Houjun [1 ]
Wang, Ziwei [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing 400016, Peoples R China
关键词
Colorectal cancer; Telomere length; Prognosis; CHEMOTHERAPY; PROGRESSION; EXPRESSION; BIOMARKER; CETUXIMAB; EROSION; MARKERS; GROWTH; CELLS;
D O I
10.1159/000438614
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: The stabilization of telomere length has important roles in the carcinogenesis of colorectal cancer. A systemic review and meta-analysis of published studies was performed to assess the prognostic role of telomere length in colorectal cancer. Methods: Pubmed and Embase were searched for eligible studies on the association between telomere length and overall survival in colorectal cancer patients. The pooled hazard ratio (HR) and corresponding 95% confidence intervals (95%CI) was calculated using fixed-effects or random-effects model according to the magnitude of between-study heterogeneity. Results: Seven individual studies with a total of 956 colorectal cancer patients were included. Long telomere length in cancer tissues was marginally associated with poorer overall survival (Random-effects HR = 1.85, 95% 0.90 to 3.83, P = 0.09). When using studies with adjusted estimates, long telomere length in cancer tissues was independently and significantly associated with poorer overall survival (Fixed-effects HR = 2.70, 95% 1.51 to 4.84, P = 0.001). However, short telomere length in peripheral blood leukocytes was independently and significantly associated with poorer overall survival (Fixed-effects HR = 2.01, 95% 1.46 to 2.77, P < 0.001). Conclusions: There is some evidence for telomere length as a prognostic factor for overall survival in colorectal cancer patients. More studies with large number of participants are needed to further assess the prognostic significance of telomere length in colorectal cancer patients. (C) 2016 The Author(s)
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [41] Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
    Zhang, Zhiqiao
    Liu, Qingbo
    Wang, Peng
    Li, Jing
    He, Tingshan
    Ouyang, Yanling
    Huang, Yiyan
    Wang, Weidong
    PEERJ, 2018, 6
  • [42] Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort study
    Luvian-Morales, Julissa
    Gonzalez-Trejo, Sagrario
    Carrillo, Jose F.
    Herrera-Goepfert, Roberto
    Aiello-Crocifoglio, Vincenzo
    Gallardo-Rincon, Dolores
    Ochoa-Carrillo, Francisco J.
    Onate-Ocana, Luis F.
    CANCER MEDICINE, 2019, 8 (07): : 3379 - 3388
  • [43] Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival
    Wang, Y.
    Fang, M.
    Sun, X.
    Sun, J.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (02) : 230 - 238
  • [44] Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients
    Li, Pan
    Xiao, Zhi-Tao
    Braciak, Todd A.
    Ou, Qing-Jian
    Chen, Gong
    Oduncu, Fuat S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11) : 702 - 706
  • [45] Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer
    Peng, Yurui
    Xu, Chenxin
    Wen, Jun
    Zhang, Yuanchuan
    Wang, Meng
    Liu, Xiaoxiao
    Zhao, Kang
    Wang, Zheng
    Liu, Yanjun
    Zhang, Tongtong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Association between telomere length and the risk of colorectal cancer: a meta-analysis of observational studies
    Naing, Cho
    Aung, Kyan
    Lai, Pei Kuan
    Mak, Joon Wah
    BMC CANCER, 2017, 17
  • [47] Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy
    Moisuc, Diana Cornelia
    Constantinescu, Daniela
    Marinca, Mihai Vasile
    Gafton, Bogdan
    Pavel-Tanasa, Mariana
    Cianga, Petru
    CANCERS, 2024, 16 (02)
  • [48] Tumor necrosis is a new promising prognostic factor in colorectal cancer
    Pollheimer, Marion J.
    Kornprat, Peter
    Lindtner, Richard A.
    Harbaum, Lars
    Schlemmer, Andrea
    Rehak, Peter
    Langner, Cord
    HUMAN PATHOLOGY, 2010, 41 (12) : 1749 - 1757
  • [49] Multiple carcinomas: Prognostic factor in patients with colorectal cancer?
    Hildebrand P.
    Humke J.
    Övermann E.
    Schlöricke E.
    Schmidt K.
    Jungbluth T.
    Roblick U.J.
    Bruch H.-P.
    Czymek R.
    coloproctology, 2010, 32 (6) : 326 - 333
  • [50] Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer
    Bai, J.
    Zhang, X.
    Xiang, Z-X
    Zhong, P-Y
    Xiong, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (03) : 1134 - 1141